Full Text View
Tabular View
No Study Results Posted
Related Studies
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma
This study has been completed.
Study NCT00043420   Information provided by Pfizer
First Received: August 8, 2002   Last Updated: February 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma, T-Cell, Cutaneous
Additional conditions recognized in this trial
Lymphoma
Lymphoma, T-Cell
Mycosis Fungoides
Sezary Syndrome
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
PF-3512676
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services